Ocular therapeutics.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage; D005128:Eye Diseases / Q000188:drug therapy* / Q000451:nursing; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007267:Injections / Q000379:methods; D008916:Miotics / Q000008:administration & dosage; D009184:Mydriatics / Q000008:administration & dosage; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D010277:Parasympathomimetics / Q000008:administration & dosage; D013566:Sympathomimetics / Q000008:administration & dosage
D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D008916:Miotics; D009184:Mydriatics; D009883:Ophthalmic Solutions; D010277:Parasympathomimetics; D013566:Sympathomimetics